Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?
news via Technology - Investor's Business Daily
Amgen stock neared its record high Friday after the company said it's "very encouraged" with midstage test results for its obesity treatment. The post Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly? appeared first on Investor's Business Daily....
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!